4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide has been researched along with Diabetic Nephropathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, H; Liu, Y; Wang, S; Wang, Z; Yin, W | 1 |
| Cai, MB; Li, HG; Li, QK; Liu, Y; Wang, ZB; Yin, WD; Yu, J; Zhang, C; Zu, XH | 1 |
2 other study(ies) available for 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide and Diabetic Nephropathies
| Article | Year |
|---|---|
Ibrolipim attenuates early-stage nephropathy in diet-induced diabetic minipigs: Focus on oxidative stress and fibrogenesis.
Topics: Animals; Antioxidants; Benzamides; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diet, High-Fat; Dietary Sucrose; Extracellular Matrix; Fibrosis; Gene Expression Regulation; Kidney; Male; Matrix Metalloproteinase 2; NADPH Oxidase 4; Organophosphorus Compounds; Oxidative Stress; Reactive Oxygen Species; Swine; Swine, Miniature; Transforming Growth Factor beta1 | 2020 |
Preventive effect of Ibrolipim on suppressing lipid accumulation and increasing lipoprotein lipase in the kidneys of diet-induced diabetic minipigs.
Topics: Albuminuria; Animals; Benzamides; Blood Glucose; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dietary Fats; Drug Evaluation, Preclinical; Enzyme Assays; Gene Expression; Hypolipidemic Agents; Insulin; Kidney; Lipid Metabolism; Lipids; Lipoprotein Lipase; Male; Organ Size; Organophosphorus Compounds; Sucrose; Swine; Swine, Miniature | 2011 |